Relay Therapeutics, Inc.
Relay Therapeutics, Inc. (RLAY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RLAY · as of Jun 9, 2026
Key Statistics
Explore Relay Therapeutics, Inc. Data
rlay stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 15 · Buy rate: 100.0%
The RLAY analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $24.00, representing +75.70% upside from the current price of $13.66.
Competitors & Peers
rlay competitorsRLAY
AMLX
CVAC
IMTX
INBX
NKTRStock Performance
Full HistoryAbout Relay Therapeutics, Inc.
Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials. Its central mission involves revolutionizing the drug discovery process, with a particular focus on enhan…
what is relay therapeutics, inc. · rlay stock overview · relay therapeutics, inc. company profile · who is relay therapeutics, inc. ceo · rlay NASDAQ · relay therapeutics, inc. headquarters · relay therapeutics, inc. business segments
About Stock Overview & Key Data
Relay Therapeutics, Inc. (RLAY) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 16, 2020. As of the latest trading session, RLAY stock price is $13.66, with a market capitalization of $2.4B. The stock has returned +306.55% over the past 12 months and +61.47% year-to-date.
According to 15 Wall Street analysts, the consensus rating for Relay Therapeutics, Inc. stock is Buy, with an average 12-month price target of $24.00. In fiscal year 2025, Relay Therapeutics, Inc. reported revenue of $15.4M and net income of -$276.5M. For detailed data — including Relay Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Relay Therapeutics, Inc. (RLAY) stock price is $13.66. The stock is traded on NASDAQ under the ticker symbol RLAY. The 52-week range is $2.98 – $17.47.